132 related articles for article (PubMed ID: 9314829)
1. Monomeric phospholamban overexpression in transgenic mouse hearts.
Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
[TBL] [Abstract][Full Text] [Related]
4. Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo.
Chu G; Li L; Sato Y; Harrer JM; Kadambi VJ; Hoit BD; Bers DM; Kranias EG
J Biol Chem; 1998 Dec; 273(50):33674-80. PubMed ID: 9837953
[TBL] [Abstract][Full Text] [Related]
5. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
Brittsan AG; Carr AN; Schmidt AG; Kranias EG
J Biol Chem; 2000 Apr; 275(16):12129-35. PubMed ID: 10766848
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658
[TBL] [Abstract][Full Text] [Related]
7. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
[TBL] [Abstract][Full Text] [Related]
8. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
10. Phospholamban gene dosage effects in the mammalian heart.
Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG
Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604
[TBL] [Abstract][Full Text] [Related]
11. Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport.
Waggoner JR; Ginsburg KS; Mitton B; Haghighi K; Robbins J; Bers DM; Kranias EG
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H698-703. PubMed ID: 19112098
[TBL] [Abstract][Full Text] [Related]
12. Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.
Chu G; Carr AN; Young KB; Lester JW; Yatani A; Sanbe A; Colbert MC; Schwartz SM; Frank KF; Lampe PD; Robbins J; Molkentin JD; Kranias EG
Cardiovasc Res; 2002 Apr; 54(1):105-16. PubMed ID: 12062367
[TBL] [Abstract][Full Text] [Related]
13. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.
Chu G; Lester JW; Young KB; Luo W; Zhai J; Kranias EG
J Biol Chem; 2000 Dec; 275(49):38938-43. PubMed ID: 10988285
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
Kiss E; Jakab G; Kranias EG; Edes I
Circ Res; 1994 Aug; 75(2):245-51. PubMed ID: 8033338
[TBL] [Abstract][Full Text] [Related]
15. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.
Zvaritch E; Backx PH; Jirik F; Kimura Y; de Leon S; Schmidt AG; Hoit BD; Lester JW; Kranias EG; MacLennan DH
J Biol Chem; 2000 May; 275(20):14985-91. PubMed ID: 10809743
[TBL] [Abstract][Full Text] [Related]
16. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Chu G; Luo W; Slack JP; Tilgmann C; Sweet WE; Spindler M; Saupe KW; Boivin GP; Moravec CS; Matlib MA; Grupp IL; Ingwall JS; Kranias EG
Circ Res; 1996 Dec; 79(6):1064-76. PubMed ID: 8943945
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
Schmidt AG; Zhai J; Carr AN; Gerst MJ; Lorenz JN; Pollesello P; Annila A; Hoit BD; Kranias EG
Cardiovasc Res; 2002 Nov; 56(2):248-59. PubMed ID: 12393095
[TBL] [Abstract][Full Text] [Related]
19. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
[TBL] [Abstract][Full Text] [Related]
20. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
Haghighi K; Schmidt AG; Hoit BD; Brittsan AG; Yatani A; Lester JW; Zhai J; Kimura Y; Dorn GW; MacLennan DH; Kranias EG
J Biol Chem; 2001 Jun; 276(26):24145-52. PubMed ID: 11328820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
